Atrás
Rango del Día
$84.94
$88.39
Rango de 52 Semanas
$36.88
$109.28
Volumen
885,313
Promedio 50D / 200D
$96.02
/
$73.30
Cierre Anterior
$89.43
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -188.8 | 0.4 |
| P/B | 14.0 | 2.9 |
| ROE % | -8.7 | 3.9 |
| Net Margin % | -4.5 | 3.8 |
| Rev Growth 5Y % | 128.5 | 10.0 |
| D/E | 1.0 | 0.2 |
Precio Objetivo de Analistas
Hold
$116.70
+32.8%
Low: $95.00
High: $140.00
EPS Futuro
-$1.62
Ingresos Est.
640 M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2030 |
$7.51
$6.93 – $8.01
|
1.6 B | 5 |
| FY2029 |
$4.85
$4.47 – $5.17
|
1.3 B | 2 |
| FY2028 |
$1.84
-$0.16 – $4.30
|
990 M | 7 |
Puntos Clave
Revenue grew 128.45% annually over 5 years — strong growth
Generating 54.87M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 73.71%
Capital efficient — spends only 0.18% of revenue on capex
Crecimiento
Revenue Growth (5Y)
128.45%
Revenue (1Y)54.74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-8.65%
ROIC-2.62%
Net Margin-4.48%
Op. Margin-4.25%
Seguridad
Debt / Equity
1.02
Current Ratio2.67
Interest Coverage-1.54
Valoración
P/E Ratio
-188.82
P/B Ratio14.02
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 54.74% | Revenue Growth (3Y) | 67.25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 128.45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 521.31M | Net Income (TTM) | -23.36M |
| ROE | -8.65% | ROA | -2.77% |
| Gross Margin | 80.71% | Operating Margin | -4.25% |
| Net Margin | -4.48% | Free Cash Flow (TTM) | 54.87M |
| ROIC | -2.62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1.02 | Current Ratio | 2.67 |
| Interest Coverage | -1.54 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -188.82 | P/B Ratio | 14.02 |
| P/S Ratio | 8.46 | PEG Ratio | 2.28 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.41B | Enterprise Value | 4.43B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 521.31M | 336.89M | 186.37M | 77.06M | 19.14M |
| Net Income | -23.36M | -87.94M | -163.42M | -135.67M | -83.99M |
| EPS (Diluted) | -0.47 | -1.85 | -4.00 | -4.02 | -2.77 |
| Gross Profit | 420.73M | 255.25M | 139.34M | 64.69M | 17.24M |
| Operating Income | -22.14M | -87.61M | -109.15M | -131.22M | -173.41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 842.81M | 670.75M | 646.62M | 352.91M | 294.65M |
| Total Liabilities | 528.12M | 445.11M | 397.95M | 210.87M | 174.44M |
| Shareholders' Equity | 314.69M | 225.64M | 248.67M | 142.04M | 120.21M |
| Total Debt | 319.45M | 317.76M | 308.14M | 2.19M | 2.61M |
| Cash & Equivalents | 296.68M | 222.50M | 286.33M | 28.00M | 31.34M |
| Current Assets | 549.68M | 392.79M | 387.54M | 190.23M | 166.59M |
| Current Liabilities | 205.80M | 126.55M | 87.06M | 64.73M | 42.60M |